Focus: GLP-1 receptor agonists, semaglutide, and diabetic eye disease Goal: Help patients and families understand benefits, risks, and when retinal monitoring matters most Evidence-Based: Preferred Practice Patterns Standards of Care Systematic Reviews Meta-Analyses Diabetic Eye Disease Knowledge Hub Start with the complete guide: Diabetic Eye Disease: The Complete Patient Guide Quick Navigation What Are GLP-1 Drugs
Like other GLP-1 therapies, side effects matter
Journal of Investigative Medicine, 2022
How long should I stay on Mounjaro
For example, an increasing number of patients have reported constant vomiting, diarrhea, pancreatitis, gastroparesis and host of other life-altering side effects
The increased energy levels that most people experience by weeks eight to twelve make this more accessible than it might have been pre-protocol